cluster2.txt
14.6 KB
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis
Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent
Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema
miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF
Hsp90 regulation of fibroblast activation in pulmonary fibrosis
Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts
Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis
Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor- Beta1 in Pulmonary Fibrosis
MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFb-PI3K-Akt pathway
The lncRNA H19 Mediates Pulmonary Fibrosis by Regulating the miR-196a/COL1A1 Axis
Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung
Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts
Inhibition of PHGDH Attenuates Bleomycin-induced Pulmonary Fibrosis
Effects of particulate matter from straw burning on lung fibrosis in mice
BARD1 mediates TGF-b signaling in pulmonary fibrosis
Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis
Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition
Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis
Mechanisms of fibrosis in coal workers' pneumoconiosis
Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs
Effect of substrate stiffness on pulmonary fibroblast activation by TGF-b
Role for alpha3 integrin in EMT and pulmonary fibrosis
Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways
Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis
Molecular targets in pulmonary fibrosis: the myofibroblast in focus
miR-92a regulates TGF-b1-induced WISP1 expression in pulmonary fibrosis
Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis
Increased alveolar soluble annexin V promotes lung inflammation and fibrosis
Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis
Re-evaluation of fibrogenic cytokines in lung fibrosis
Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis
Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2
A critical role for the mTORC2 pathway in lung fibrosis
Amplification of TGFb Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis
Fibrotic myofibroblasts manifest genome-wide derangements of translational control
Inhibition and role of let-7d in idiopathic pulmonary fibrosis
Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase
Predisposition for disrepair in the aged lung
MicroRNA regulatory networks in idiopathic pulmonary fibrosis
Macrophage Bone Morphogenic Protein Receptor 2 (BMPR2) depletion in Idiopathic Pulmonary Fibrosis (IPF) and Group III Pulmonary Hypertension
Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis
Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis
Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis
[Idiopathic pulmonary fibrosis and lung cancer]
Role of caveolin-1 in fibrotic diseases
Latent cytomegalovirus infection exacerbates experimental pulmonary fibrosis by activating TGF-b1
Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis
miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-b Receptor II
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Lysocardiolipin acyltransferase regulates TGF-b mediated lung fibroblast differentiation
Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4
[Potential role of cytokines in idiopathic pulmonary fibrosis]
The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2
Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10
Therapeutic targets in fibrotic pathways
Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of Caveolin-1 and TGF-b1 Signal Pathway
Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis
Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
Profibrotic role of WNT10A via TGF-b signaling in idiopathic pulmonary fibrosis
Mesenchymal Stem Cells Correct Inappropriate Epithelial-mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1
microRNA-1343 attenuates pathways of fibrosis by targeting the TGF-b receptors
Effect of Renshen Pingfei Decoction, a traditional Chinese prescription, on IPF induced by Bleomycin in rats and regulation of TGF-b1/Smad3
M2 macrophages induce EMT through the TGF-b/Smad2 signaling pathway
Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production
miR -221 targets HMGA2 to inhibit bleomycin -induced pulmonary fibrosis by regulating TGF -b1/Smad3-induced EMT
Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen Production
Autophagy in idiopathic pulmonary fibrosis
Overexpression of Sulf2 in idiopathic pulmonary fibrosis
Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis
Matrix metalloproteinase (MMP)-19 deficient fibroblasts display a profibrotic phenotype
[Pulmonary fibrosis--a therapeutic dilemma?]
Signaling pathways in the epithelial origins of pulmonary fibrosis
FGF-1 reverts epithelial-mesenchymal transition induced by TGF-{beta}1 through MAPK/ERK kinase pathway
Participation of miR-200 in pulmonary fibrosis
Proteasomal regulation of pulmonary fibrosis
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation
Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-b Induced Myofibroblast Differentiation via Prostaglandin E2
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Inhibition of the KCa3.1 Channel Alleviates Established Pulmonary Fibrosis in a Large Animal Model
Human lung myofibroblast TGFb1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channels
AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation
Transforming growth factor-beta1 in sarcoidosis
The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis
Cytokines in human lung fibrosis
MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis
Novel Mechanisms for the Antifibrotic Action of Nintedanib
Determining the True Selectivity Profile of av Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem
Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia
Cytokine gene polymorphisms in idiopathic pulmonary fibrosis
Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis
Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFb-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis
Cub domain containing protein 1 (CDCP1) negatively regulates TGFb signaling and myofibroblast differentiation
The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-b1 pathway in human lung fibroblasts
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin avb6 Expression
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition
Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis
Pulmonary fibrosis: pathogenesis, etiology and regulation
Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2
Profibrotic role of miR-154 in pulmonary fibrosis
miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis
Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-b1/Smad3 pathway via miR-140 upregulation
IPF lung fibroblasts have a senescent phenotype
MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition
MAP3K19 Is a Novel Regulator of TGF-b Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis
N-acetyl-L-cysteine inhibits TGF-beta1-induced profibrotic responses in fibroblasts
Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-b1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt
Sphingolipids in pulmonary fibrosis
Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways
Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis
Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts: Possible Implications in Idiopathic Pulmonary Fibrosis
BALF N-acetylglucosaminidase and beta-galactosidase activities in idiopathic pulmonary fibrosis
Transglutaminase 2 and its role in pulmonary fibrosis
The role of cytokines in human lung fibrosis
miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2
Regulation of 26S Proteasome Activity in Pulmonary Fibrosis
Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis
Pleural mesothelial cells in pleural and lung diseases
[Different cytokine profiles in usual interstitial pneumonia and nonspecific interstitial pneumonia]
Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis
Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFb1
The Role of PPARs in Lung Fibrosis
MiR-338* suppresses fibrotic pathogenesis in pulmonary fibrosis through targeting LPA1
Metformin attenuates lung fibrosis development via NOX4 suppression
Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF)
The pathogenesis of idiopathic pulmonary fibrosis
Interstitial fibrosis and growth factors
TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis
Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis
Leucine-rich a-2 glycoprotein promotes lung fibrosis by modulating TGF-b signaling in fibroblasts
MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A
Lipoxin A4 Attenuates Constitutive and TGF-b1-Dependent Profibrotic Activity in Human Lung Myofibroblasts
Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis
TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice
Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells
Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF
TGF-b1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts
Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes
Epithelial-mesenchymal transition in chronic hypersensitivity pneumonitis
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
HSP27 regulates TGF-b mediated lung fibroblast differentiation through the Smad3 and ERK pathways
Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
[A role for mesothelial cells in the genesis of idiopathic pulmonary fibrosis?]
Pathogenesis of idiopathic pulmonary fibrosis
SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis
TGF-b activation and lung fibrosis
Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice
[The potential role of cytokines expression in idiopathic pulmonary fibrosis]
CXCL9 Regulates TGF-b1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells
Autophagy and inflammation in chronic respiratory disease
Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo
Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis
Membrane type-matrix metalloproteinases in idiopathic pulmonary fibrosis
Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1
Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFb1
EMT and interstitial lung disease: a mysterious relationship
Anti-fibrotic Role of aB-crystallin Inhibition in Pleural and Subpleural Fibrosis
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
MicroRNAs in idiopathic pulmonary fibrosis
Yin yang 1 is a novel regulator of pulmonary fibrosis
Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition
Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-b and WNT7B in Human Lung Fibroblasts
Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10)